SCHEDULE 13G/A 0000935836-24-000701 0001105806 XXXXXXXX LIVE 3 Common Stock 12/31/2024 0001279704 Cellectar Biosciences, Inc. 15117F807 100 Campus Drive Florham Park NJ 07932 Rule 13d-1(c) LYTTON LAURENCE W X1 3955470.00 0.00 3955470.00 0.00 3955470.00 N 8.8 IN The Common Stock beneficially owned by the reporting person consists of (1) 503,296 shares of Common Stock, and (2) warrants to acquire 3,452,174 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. Percentage calculated based on 41,269,830 shares of Common Stock outstanding on November 18, 2024, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2024. Cellectar Biosciences, Inc. 100 Campus Drive, Florham Park, NJ 07932 Laurence W. Lytton 467 Central Park West New York, NY 10025 USA Y 3,955,470 8.8% 3,955,470 0 3,955,470 0 N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. LYTTON LAURENCE W /s/ Laurence W. Lytton 02/13/2025